Scholar Rock Holding (SRRK) Other financing activities (2018 - 2026)
Scholar Rock Holding's quarterly Other financing activities came in at $1.3 million in Q1 2026, up 65500.0% year-on-year from N/an in Q1 2025, and up 65500.0% quarter-over-quarter from $2000.0 in Q1 2025.
Scholar Rock Holding has reported Other financing activities for 7 years, with the latest figure at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities rose 65500.0% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 43700.0% YoY), and the FY2023 full-year result was $3000.0, changed N/A from the prior year.
- Other financing activities for Q1 2026 stood at $1.3 million, up from $2000.0 in the prior quarter.
- The five-year high for Other financing activities was $1.3 million in Q1 2026, with the low at $1000.0 in Q2 2023.
- Average Other financing activities over 3 years is $329250.0, with a median of $2000.0 recorded in 2023.
- Peak annual rise in Other financing activities reached 65500.0% in 2026, while the deepest fall reached 65500.0% in 2026.
- Tracing SRRK's Other financing activities over 3 years: stood at $1000.0 in 2023, then jumped by 100.0% to $2000.0 in 2025, then surged by 65500.0% to $1.3 million in 2026.
- The last three Other financing activities figures came in at $1.3 million (Q1 2026), $2000.0 (Q1 2025), and $1000.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.31 Mn |
| Mar 31, 2026 | 1.31 Mn |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | -9,000.00 |
| Sep 30, 2021 | -9,000.00 |
| Jun 30, 2021 | -4,000.00 |
| Jun 30, 2021 | -4,000.00 |
| Mar 31, 2021 | -6,000.00 |
| Mar 31, 2021 | -6,000.00 |
| Dec 31, 2020 | -4,000.00 |
| Dec 31, 2020 | -4,000.00 |
| Sep 30, 2020 | -6,000.00 |
| Sep 30, 2020 | -6,000.00 |
| Jun 30, 2020 | -3,000.00 |
| Jun 30, 2020 | -3,000.00 |
| Mar 31, 2020 | -6,000.00 |
| Mar 31, 2020 | -6,000.00 |
| Dec 31, 2019 | -3,000.00 |
| Dec 31, 2019 | -3,000.00 |
| Sep 30, 2019 | -4,000.00 |
| Sep 30, 2019 | -4,000.00 |
| Jun 30, 2019 | -3,000.00 |
| Jun 30, 2019 | -3,000.00 |
| Mar 31, 2019 | -3,000.00 |
| Mar 31, 2019 | -3,000.00 |
| Dec 31, 2018 | -4,000.00 |
| Dec 31, 2018 | -4,000.00 |